Details Meeting Name: Committee on Health Agenda status: Final Meeting date/time: 9/20/2023 10:00 AM Minutes status: Final   Meeting location: Council Chambers - City Hall Jointly with the Committee on Hospitals Published agenda: Agenda Published minutes: Minutes   Meeting video: Video   Attachments: CLICK ANY FILE # BELOW (in blue) TO ACCESS LEGISLATION AND ATTACHMENTS Meeting Items (9) 9 records Group Clear sorting Clear grouping Group by Type Group by Result Export Export to Excel Export to PDF Export to Word Show: All agenda items Legislation only All agenda items File # Ver. Prime Sponsor Agenda # Agenda Note Name Type Summary Action Result Action Details Multimedia                     Roll call Not available T2023-3955 *       Oversight - Evaluating Access to Sickle Cell Care in NYC. Oversight   Hearing Held by Committee   Action details Not available T2023-3955 *       Oversight - Evaluating Access to Sickle Cell Care in NYC. Oversight   Filed, by Committee   Action details Not available Res 0771-2023 * Mercedes Narcisse     Sickle Cell Treatment Act. (S1839A/A2609 and S1890/A2661) Resolution   Hearing Held by Committee   Action details Not available Res 0771-2023 * Mercedes Narcisse     Sickle Cell Treatment Act. (S1839A/A2609 and S1890/A2661) Resolution   Laid Over by Committee   Action details Not available Int 0968-2023 * Mercedes Narcisse   Proposed Int. No. 968-A Establishing guidance to improve health outcomes for individuals affected by sickle cell disease. Introduction This bill would require the Department of Health and Mental Hygiene, in consultation with New York City Health and Hospitals, to create guidance to educate medical professionals and the public on the detection of the sickle cell trait through pre- and post-conception genetic screening and on the management and treatment of sickle cell disease. Guidance for medical professionals is required to include education on the benefits of recommending screenings during the family planning process and on nondiscriminatory approaches to assess patient pain, including instruction on implicit bias in the provision of pain management. The bill would also require that pre- and post- conception genetic screening for sickle cell trait be offered to those who fall into an at-risk population or for whom such screening is otherwise medically recommended. Hearing Held by Committee   Action details Not available Int 0968-2023 * Mercedes Narcisse     Establishing guidance to improve health outcomes for individuals affected by sickle cell disease. Introduction This bill would require the Department of Health and Mental Hygiene, in consultation with New York City Health and Hospitals, to create guidance to educate medical professionals and the public on the detection of the sickle cell trait through pre- and post-conception genetic screening and on the management and treatment of sickle cell disease. Guidance for medical professionals is required to include education on the benefits of recommending screenings during the family planning process and on nondiscriminatory approaches to assess patient pain, including instruction on implicit bias in the provision of pain management. The bill would also require that pre- and post- conception genetic screening for sickle cell trait be offered to those who fall into an at-risk population or for whom such screening is otherwise medically recommended. Amendment Proposed by Comm   Action details Not available Int 0968-2023 * Mercedes Narcisse     Establishing guidance to improve health outcomes for individuals affected by sickle cell disease. Introduction This bill would require the Department of Health and Mental Hygiene, in consultation with New York City Health and Hospitals, to create guidance to educate medical professionals and the public on the detection of the sickle cell trait through pre- and post-conception genetic screening and on the management and treatment of sickle cell disease. Guidance for medical professionals is required to include education on the benefits of recommending screenings during the family planning process and on nondiscriminatory approaches to assess patient pain, including instruction on implicit bias in the provision of pain management. The bill would also require that pre- and post- conception genetic screening for sickle cell trait be offered to those who fall into an at-risk population or for whom such screening is otherwise medically recommended. Laid Over by Committee   Action details Not available                     Not available